Freeman Spogli Institute for International Studies Center for Health Policy/Center for Primary Care and Outcomes Research Stanford University


Photo of Mark Hlatky

Mark A. Hlatky, MD   Download vCard
Professor of Health Research and Policy and of Medicine (Cardiovascular Medicine) and Stanford Health Policy Fellow

Department of Health Research and Policy
Stanford University
Redwood Bldg, T150A
Stanford, CA 94305-5405
(650) 723-6426 (voice)
(650) 725-6951 (fax)

Research Interests
outcomes research, clinical trials, cost-effectiveness

Mark Hlatky is a professor of Health Research and Policy and of medicine (cardiovascular medicine) at Stanford, as well as a CHP/PCOR fellow. His major interests are in outcomes research, evidence-based medicine, and cost-effectiveness analysis. He introduced data collection about economic and quality of life endpoints in several randomized trials, principally trials of therapies for cardiovascular disease.

Hlatky received his MD from the University of Pennsylvania, and, after residency at the University of Arizona, studied as a Robert Wood Johnson Clinical Scholar at the University of California, San Francisco. He trained in cardiology at Duke University Medical Center, and then joined the Duke faculty. He has been at the Stanford University School of Medicine since 1989, where he is currently professor and chair of Health Research and Policy.

Stanford Departments
Health Research and Policy


The 5 most recent are displayed. More publications »

Events & Presentations

The 5 most recent are displayed. More events & presentations »

Research Programs & Projects

News around the web

CABG, PCI debate continues with new research, emerging technologies
Research performed in 2009 by Mark Hlatky, MD, professor of health research and policy and of medicine, Stanford University, and colleagues examined the ...
October 1, 2010 in Cardiology Today

Statins Could Prevent More Strokes, Heart Attacks: Analysis
... Dr. Mark Hlatky, professor of health research and policy and of cardiovascular medicine at Stanford University School of Medicine in Stanford, Calif., ...
September 27, 2010 in BusinessWeek

Study: Putting More People on Cholesterol-Lowering Drugs Could Save Money
Now scientists at Stanford University report an economic benefit to taking statins: putting more patients on the cholesterol medication may be a ...
September 27, 2010 in TIME

Wider statin use may be cost-effective way to prevent heart attack, stroke
Whether expanding statin use as a preventive strategy would be cost-effective, though, remained an unanswered question - and Stanford researchers did their ...
September 27, 2010 in Scope (blog)